HDAC-mediated modifications are essential for maintaining CAF gene expression and function [253], while the HDAC inhibitor (HDACi) scriptaid can delay tumor growth by reversing CAF activation and function [254]. The gene discussed is HDAC9; the disease is neoplasm.